Vectors comprising a special translation-regulating system

Filing statistics

CPC C12N 2840/00 belongs to the parent subclass C12N, which recorded 645,915 patent applications worldwide between 2013 and 2023. Annual filings grew from 37,975 in 2013 to 61,537 in 2023 (+62%), peaking at 73,818 applications in 2021. The most active applicants in class C12 are HARVARD UNIVERSITY (8,321 applications), CHINESE ACADEMY OF SCIENCES (7,486 applications) and UNIVERSITY OF CALIFORNIA (7,320 applications).

Source: EPO PATSTAT, worldwide filings

13 direct subcodes

Child Classifications

Navigate with arrow keys, Enter to open

C12N 2840/002 controllable or inducible
C12N 2840/005 cell cycle specific
C12N 2840/007 cell or tissue specific
C12N 2840/10 regulates levels of translation
C12N 2840/20 translation of more than one cistron
C12N 2840/44 being a specific part of the splice mechanism, e.g. donor, acceptor
C12N 2840/50 utilisation of non-ATG initiation codon
C12N 2840/55 from bacteria
C12N 2840/60 from viruses
C12N 2840/65 from plants
C12N 2840/70 from fungi
C12N 2840/75 from invertebrates
C12N 2840/80 from vertebrates

Top Applicants

Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT

HARVARD UNIVERSITY US 8,321
CHINESE ACADEMY OF SCIENCES 7,486
UNIVERSITY OF CALIFORNIA US 7,320
REGENERON PHARMACEUTICALS US 5,003
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
UNIVERSITY OF PENNSYLVANIA US 4,213
CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
JIANGNAN UNIVERSITY 3,961
ROCHE CH 3,792
ILLUMINA US 3,692